Sort
82,697 grants matching “vaccine development”
Glycosylation Mutants of Leishmania
$744,807Stephen M Beverley · Washington University · R01 · FY2012 · AI
Role of HIV Envelope Proteins In Viral Replication and HIV Pathogenesis
$744,742Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Interaction of HIV envelope with cell surface receptors
$744,742Anthony S. Fauci · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Dissecting Hepatitis B Vaccine Adjuvant Effects on Immune Responses and the HIV Reservoir in PLWH
$744,728Andrea L Cox · Johns Hopkins University · R01 · FY2024 · AI
Translational Geroscience Network
$744,685Robert John Pignolo · Mayo Clinic Rochester · R33 · FY2024 · AG
Pre-clinical Commercialization of a Synthetically Designed, Live-attenuated RSV Vaccine
$744,622Steffen Mueller · Codagenix, Inc. · R44 · FY2018 · AI
Combined adjuvant approaches for enhancement of SARS-CoV-2 vaccine efficacy
$744,600Pamela Tinmoi Wong · University Of Michigan At Ann Arbor · R01 · FY2022 · AI
Biological vector control reducing arboviruses, including Dengue and Chikungunya
$744,582James William Mains · Mosquitomate, Inc. · R44 · FY2015 · AI
Mechanisms of vitamin A-dependent risk for tuberculosis progression and prevention
$744,535Brendan Podell · Colorado State University · R01 · FY2024 · AI
Antigen presentation by epithelial stem cells to promote life long immunity
$744,517Marie-Claire Elisabeth Gauduin · Texas Biomedical Research Institute · R01 · FY2012 · AI
EpiModel 2.0: Integrated Network Models for HIV/STI Prevention Science
$744,465Samuel Jenness · Emory University · R01 · FY2019 · AI
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$744,264Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
THERAPEUTIC COCAINE VACCINE
$744,249Yale University · U19 · FY2000 · DA
A Phylodynamic Artificial Intelligence framework to predict evolution of SARS-CoV-2 variants of concern in Immunocompromised persons with HIV (PhAI-CoV)
$744,241Marco Salemi · University Of Florida · R01 · FY2023 · AI
Escape of maternal plasma broadly neutralizing antibody as a mechanism of mother to child HIV transmission
$744,209Sallie R. Permar · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · AI
Translational studies of hookworm infection in Ghana
$744,203Michael Cappello · Yale University · R01 · FY2024 · AI
Translational studies of hookworm infection in Ghana
$744,203Michael Cappello · Yale University · R01 · FY2023 · AI
Washington Entrepreneurial Research Evaluation and Commercialization Hub
$744,200Rodney J.y. Ho · University Of Washington · U01 · FY2020 · HL
Epigenetics of severe asthma
$744,199Pandurangan Vijayanand · La Jolla Institute For Immunology · R01 · FY2018 · HL
Administrative Core
$744,160Dennis L. Kasper · Harvard Medical School · U54 · FY2010 · AI
Center for Humanized Mice
$744,154Larisa Y Poluektova · University Of Nebraska Medical Center · R24 · FY2017 · OD
The Role of Nasal Mucosal Immunity and Microbiome on the Frequent Exacerbation Phenotype of COPD
$744,150Michael Bradley Drummond · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
Immune reconstitution following autologous and allogeneic stem cell transplant
$744,123Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2011 · CA
IGF::OT::IGF COORDINATION AND TECHNICAL SUPPORT
$744,095Thomas Hassell · International Aids Vaccine Initiative · N01 · FY2016 · AI
Development of highly neutralizing nanobodies against HIV-1 and SARS-CoV-2
$743,993Rafael C Casellas · National Institute Of Arthritis And Musculoskeletal And Skin Diseases · ZIA · FY2021 · AR